When to Add Insulin for Type 2 Diabetes
Insulin should be initiated immediately at diagnosis when blood glucose is ≥300 mg/dL or HbA1c is ≥10%, especially if the patient has symptoms of hyperglycemia (polyuria, polydipsia, weight loss) or evidence of catabolism. 1
Immediate Insulin Initiation Criteria
Start insulin at diagnosis if any of the following are present:
- Blood glucose ≥300-350 mg/dL 1
- HbA1c ≥10% (86 mmol/mol) 1
- Symptomatic hyperglycemia (polyuria, polydipsia, nocturia, weight loss) 1
- Evidence of catabolism (unintentional weight loss, hypertriglyceridemia, ketosis) 1
In these situations, insulin therapy should be started with or without additional agents to rapidly correct glucose toxicity. 1 Once metabolic stabilization occurs, the regimen can often be simplified or transitioned to oral agents. 1
Insulin After Oral Agent Failure
Add basal insulin when:
- HbA1c remains above target after 3 months on metformin plus one or two additional oral agents 1
- Metformin contraindications or intolerance develop and HbA1c is not at goal 1
- HbA1c is 1.5-2.0% above target despite dual oral therapy 1
The American Diabetes Association guidelines emphasize that basal insulin should be added when oral agents fail to maintain glycemic control, typically when HbA1c exceeds 7% on maximally tolerated doses. 1
Special Populations
For youth with type 2 diabetes:
- Start basal insulin if HbA1c ≥8.5% (69 mmol/mol) with symptoms (blood glucose ≥250 mg/dL) while initiating metformin 1
- Use insulin plus metformin for ketosis/ketoacidosis at presentation 1
Practical Implementation
Initial basal insulin dosing:
- Start with 10 units daily or 0.1-0.2 units/kg depending on hyperglycemia severity 1
- Titrate by 2-4 units every 3-7 days until fasting glucose reaches target (80-130 mg/dL) 1, 2
- Continue metformin when adding insulin to reduce insulin requirements and minimize weight gain 1
If basal insulin alone is insufficient (dose >0.5 units/kg/day or HbA1c still above target):
- Add one injection of rapid-acting insulin before the largest meal (starting at 4 units or 10% of basal dose) 1, 2
- Alternatively, add a GLP-1 receptor agonist (associated with weight loss and less hypoglycemia but higher cost) 1
- Or switch to twice-daily premixed insulin 1
Common Pitfalls to Avoid
Do not delay insulin when clearly indicated. Prolonged exposure to severe hyperglycemia (HbA1c >9% for months) increases complication risk and should be specifically avoided. 2 The progressive nature of type 2 diabetes means most patients will eventually require insulin, and it should not be presented as a failure or punishment. 1
Avoid relying solely on sliding-scale insulin without optimizing basal insulin first—this approach is ineffective for long-term management. 2
Do not add a third oral agent when HbA1c is ≥10% without concurrent insulin therapy, as oral agents typically reduce HbA1c by only 0.7-1.0% each. 1, 2
Weight and Hypoglycemia Considerations
Insulin therapy causes weight gain (average 1.9-3.7 kg), which can be minimized by continuing metformin and considering addition of GLP-1 receptor agonists or SGLT2 inhibitors. 1 Sulfonylureas should typically be discontinued when advancing to complex insulin regimens beyond basal insulin to reduce hypoglycemia risk. 1, 2